We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · October 18, 2021

Once-Daily Mometasone/Indacaterol vs Twice-Daily Fluticasone/Salmeterol in Patients With Inadequately Controlled Asthma

BMJ Open Respiratory Research


Additional Info

Disclosure statements are available on the authors' profiles:

BMJ Open Respiratory Research
One time a day mometasone/indacaterol fixed-dose combination versus two times a day fluticasone/salmeterol in patients with inadequately controlled asthma: pooled analysis from PALLADIUM and IRIDIUM studies
BMJ Open Respir Res 2021 Aug 01;8(1)e000819, K Chapman, R van Zyl-Smit, J Maspero, HAM Kerstjens, Y Gon, M Hosoe, AM Tanase, A Pethe, X Shu, P D'Andrea

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.